Mindmed to attend 8th annual "mobile in clinical trials" conference

New york, sept. 9, 2021 /prnewswire/ -- mind medicine (mindmed) inc. (nasdaq: mnmd), (neo: mmed), (de: mmq) (the "company"), a leading biotech company developing psychedelic-inspired therapies, is pleased to announce that its chief medical officer, daniel r.
MNMD Ratings Summary
MNMD Quant Ranking